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Abstract  Streptococcus  dysgalactiae  subsp.  equisimilis  (SDSE)  has  virulence  factors  similar  to
those of  Streptococcus  pyogenes.  Therefore,  it  causes  pharyngitis  and  severe  infections  indis-
tinguishable  from  those  caused  by  the  classic  pathogen.  The  objectives  of  this  study  were:  to
know the  prevalence  of  SDSE  invasive  infections  in  Argentina,  to  study  the  genetic  diversity,
to determine  the  presence  of  virulence  genes,  to  study  antibiotic  susceptibility  and  to  detect
antibiotic  resistance  genes.  Conventional  methods  of  identiﬁcation  were  used.  Antibiotic  sus-
ceptibility was  determined  by  the  disk  diffusion  and  the  agar  dilution  methods  and  the  E-test.
Twenty eight  centers  from  16  Argentinean  cities  participated  in  the  study.  Twenty  three  iso-
lates (16  group  G  and  7  group  C)  were  obtained  between  July  1  2011  and  June  30  2012.  Two
adult patients  died  (8.7%).  Most  of  the  isolates  were  recovered  from  blood  (60.9%).  All  isolates
carried speJ  and  ssa  genes.  stG62647,  stG653  and  stG840  were  the  most  frequent  emm  types.
Nineteen  different  PFGE  patterns  were  detected.  All  isolates  were  susceptible  to  penicillin  and
levoﬂoxacin,  6  (26.1%)  showed  resistance  or  reduced  susceptibility  to  erythromycin  [1  mef(A),
3 erm(TR),  1  mef(A)  +  erm(TR)  and  1  erm(TR)  +  erm(B)]  and  7  (30.4%)  were  resistant  or  exhibited
reduced susceptibility  to  tetracycline  [2  tet(M),  5  tet(M)  +  tet(O)].  The  prevalence  in  Argentina
was of  at  least  23  invasive  infections  by  SDSE.  A  wide  genetic  diversity  was  observed.  All  isolates∗ Corresponding author.
E-mail address: fernandotraverso@yahoo.com.ar (F. Traverso).
♦ The complete list of centers of the National Collaborative Group for the Study of Streptococci and Related Bacteria is included in
Appendix 1.
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0325-7541/© 2016 Asociacio´n Argentina de Microbiolog´ıa. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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carried  speJ  and  ssa  genes.  Similarly  to  other  studies,  macrolide  resistance  (26.1%)  was  mainly
associated  to  the  MLSB phenotype.
© 2016  Asociacio´n  Argentina  de  Microbiolog´ıa.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Caracterización  molecular  de  cepas  invasivas  de  Streptococcus  dysgalactiae  subsp.
equisimilis.  Estudio  multicéntrico  Argentina  2011--2012
Resumen  Streptococcus  dysgalactiae  subsp.  equisimilis  (SDSE)  posee  factores  de  virulencia
similares  a  Streptococcus  pyogenes  y,  en  consecuencia,  produce  faringitis  e  infecciones  graves
indistinguibles  de  las  generadas  por  este  patógeno  clásico.  Los  objetivos  del  estudio  fueron
conocer  la  prevalencia  de  SDSE  en  infecciones  invasivas  en  Argentina,  estudiar  su  diversidad
genética, determinar  la  presencia  de  genes  de  virulencia,  ensayar  su  sensibilidad  a  los  antibióti-
cos y  conocer  los  genes  de  resistencia.  Se  emplearon  métodos  convencionales  de  identiﬁcación.
La sensibilidad  se  determinó  por  difusión,  Etest  y  dilución  en  agar.  Participaron  28  centros  de
16 ciudades  argentinas.  Se  obtuvieron  23  aislamientos  (16  del  grupo  G  y  7  del  grupo  C)  desde  el
1-7-2011 hasta  el  30-6-2012.  Se  registraron  2  muertes  en  adultos  (8,7%).  La  mayoría  de  los  ais-
lamientos  fueron  obtenidos  de  sangre  (60,9%).  Todos  eran  portadores  de  los  genes  speJ  y  ssa. Los
genotipos más  frecuentes  fueron  stG62647,  stG653  y  stG840.  Se  detectaron  19  pulsotipos  distin-
tos. Todos  los  aislamientos  fueron  sensibles  a  penicilina  y  levoﬂoxacina,  6  (26,1%)  presentaron
resistencia  o  sensibilidad  disminuida  a  eritromicina  (1  mef[A],  3  erm[TR],  1  mef[A]  +  erm[TR]  y  1
erm[TR] +  erm[B])  y  7  (30,4%)  fueron  resistentes  o  tuvieron  sensibilidad  disminuida  a  tetraciclina
(2 tet[M],  5  tet[M]  +  tet[O]).  La  prevalencia  anual  en  la  Argentina  fue  de  al  menos  23  infecciones
invasivas por  SDSE  y  se  observó  una  amplia  diversidad  genética.  Todos  los  aislamientos  presen-
taron los  genes  ssa  y  speJ.  Como  en  otros  estudios,  la  resistencia  a  macrólidos  (26,1%)  estuvo
asociada,  principalmente,  al  fenotipo  MLSB.
© 2016  Asociacio´n  Argentina  de  Microbiolog´ıa.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
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-Hemolytic  streptococci  are  common  pathogens  that  usu-
lly  cause  community-acquired  infections.
In  general,  -hemolytic  streptococci  isolated  from  human
eings  belong  to  Lanceﬁeld  groups  A,  B,  C,  G,  F,  or  more
arely,  to  L18.  Until  recently,  group  A  streptococci  (GAS,
treptococcus  pyogenes)63 and  group  B  streptococci  (GBS,
treptococcus  agalactiae)45,60 were  considered  the  most
mportant  pathogens  of  this  group  of  microorganisms  in  clin-
cal  settings.
GAS  is  responsible  for  a  broad  spectrum  of  human
nfections  that  result  in  signiﬁcant  morbidity  and  mor-
ality,  including  pharyngitis,  scarlet  fever,  skin  and  soft
issue  infection  (SSTI),  streptococcal  toxic  shock  syndrome
STSS),  septicemia,  pneumonia  and  rarely  meningitis13.  It
s  estimated  that  severe  GAS  diseases  lead  to  more  than
00,000  deaths  each  year  via  infections  such  as  acute
heumatic  fever,  rheumatic  heart  disease,  post  streptococ-
al  glomerulonephritis  and  invasive  diseases8.
In  contrast,  group  C  and  G  Streptococcus  dysgalactiae
ubsp.  equisimilis  (GCS  and  GGS)  were  long  considered  to  be
ommensal  organisms  that  only  rarely  cause  invasive  infec-
ions  as  opportunistic  pathogens.Since  the  mid-1980s  there  has  been  a  marked  increase  in
eported  invasive  group  A  infections,  including  cases  of  STSS
n  Europe  and  North  America15,33,57.
t
AThese  fulminant  infections  were  characterized  by  acute
ypotension,  shock,  multiorgan  impairment  and  death.  How-
ver,  the  factors  underlying  the  worldwide  resurgence  of  this
athogen  remain  unknown16.
In  1996,  Vandamme  et  al62. proposed  that  a novel  sub-
pecies,  S.  dysgalactiae  subsp.  equisimilis  (SDSE),  was  a
linically  signiﬁcant  pathogen.  This  microorganism  possesses
roup  C  or  G  antigens  (rarely  A  or  L),  and  exhibits  strong
-hemolysis.
Beginning  around  the  year  2000,  invasive  infections  such
s  bacteremia  caused  by  SDSE  as  well  as  those  caused  by  GAS
nd  GBS6,12,38,59 have  been  increasingly  reported  worldwide.
M  proteins  of  GAS,  which  are  encoded  by  emm  genes  and
orm  elongated  structures  on  the  bacterial  surface,  play  an
mportant  role  in  the  pathogenesis  of  this  microorganism.
 proteins  are  known  to  be  critical  antiphagocytic  con-
tituents  of  GAS  due  to  their  role  in  resistance  to
psonization4,14.  GCS  and  GGS  have  shown  a  similar
athogenic  pattern  to  S.  pyogenes21, coincidently  express-
ng  homologs  of  the  M  virulence  proteins  of  S.  pyogenes7.
oreover,  some  strains  contain  superantigen  genes  ﬁrstly
haracterized  in  S.  pyogenes25,29.  As  with  the  emm  genes
f  S.  pyogenes,  GCS  and  GGS  homologs  have  been  used  for
equence-based  typing3,17,25.We  conducted  a  prospective  study  to  assess  the  rela-
ive  prevalence  of  SDSE  versus  GAS  in  invasive  infections  in
rgentina  during  a  twelve-month  period.  The  objective  of
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PMolecular  characterization  of  invasive  SDSE  in  Argentina  
this  study  was  to  determine  their  epidemiological  features,
to  explore  the  molecular  characteristics  of  the  infecting
strains,  to  study  their  genetic  diversity,  virulence  genes,
antibiotic  susceptibility  and  antibiotic  resistance  genes.
Materials and methods
All  S.  pyogenes  and  SDSE  isolated  from  invasive  infections
in  28  centers  of  16  Argentinean  cities  from  July  1,  2011  to
June  30,  2012  were  studied.
A  microbiologist  from  each  hospital  was  required  to  com-
plete  a  data  sheet  of  the  isolates.  During  the  study  period,
each  laboratory  collected  one  isolate  per  patient  in  accor-
dance  with  the  case  deﬁnition.  Isolates  were  appropriately
sent  to  the  reference  center  where  they  were  preserved  in
300  l  of  sheep  blood  at  −80 ◦C.
Deﬁnitions
Infections  in  deep  tissues,  blood,  cerebrospinal  ﬂuid,  or
other  liquids  obtained  by  puncture,  in  which  causative
organisms  were  isolated  from  otherwise  sterile  samples,
were  deﬁned  as  invasive  infections.
STSS  was  deﬁned  as  an  invasive  infection  due  to
the  presence  of  a  -hemolytic  streptococcus  and  causing
hypotension  and  two  or  more  of  the  following  conditions:
renal  impairment,  coagulopathy,  liver  abnormalities,  acute
respiratory  distress  syndrome,  extensive  tissue  necrosis  and
erythematous  rash55.
Identiﬁcation
S.  pyogenes  and  SDSE  were  identiﬁed  according  to  the
differentiating  characteristics  described  by  Ruoff  et  al49.
Hemolysis  was  detected  on  5%  sheep  blood  Columbia  agar
and  the  observation  of  chains  was  performed  in  Gram  smears
prepared  with  drops  of  overnight  cultures  in  thioglycolate
broth.  Conventional  identiﬁcation  included  the  follow-
ing  tests:  pyrrolidonyl--naphthylamide  hydrolysis  (PYR),
bacitracin  susceptibility,  cell  morphology  and  Gram  stain-
ing  characteristics,  Voges-Proskauer,  arginine  dihydrolase,
esculin,  starch,  sorbitol  and  trehalose  fermentation,-
galactosidase  and  -glucuronidase.  PYR  and  bacitracin
tests  were  performed  by  using  Britania® disks  (Buenos
Aires,  Argentina).  Sorbitol,  trehalose,  -galactosidase  and
-glucuronidase  were  tested  by  using  DIATABS® commer-
cial  tablets  (Rosco,  Taastrup,  Denmark)  according  to  the
manufacturer’s  instructions.  Voges-Proskauer,  arginine  dihy-
drolase,  esculin,  and  starch  tests  were  performed  by
standard  methods.  Moreover,  identiﬁcation  was  performed
using  API  20  Strep® (Biomérieux  Argentina).  Identiﬁcation
and  grouping  were  completed  by  using  the  latex  agglutina-
tion  method  (Slidex  Strepto  kit®,  Biomérieux  Argentina).
emm  typing
GAS  emm  DNA  fragment  preparation  was  conducted  accord-
ing  to  the  protocol  of  the  Centers  for  Disease  Control  and
Prevention  (CDC)9.
As  speciﬁed  by  the  CDC  protocol,  primers  1  and  2  were
used  for  amplifying  the  N-terminal  region  of  the  emm
W
C
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ene  [primer  1 was  5’-TATT(C/G)  GCTTAGAAAATTAA-3’,  and
rimer  2  was  5’-GCAAGTTCTTCAGCTTGTTT-3’].  The  DNA
mplicons  were  sent  for  DNA  sequencing.  The  ﬁrst  160  bases
f  the  5  end  of  the  emm  gene  were  compared  with  those
n  the  CDC  emm  sequence  database  (http://www.cdc.gov/
cidod/biotech/strep/strepblast.htm).  An  emm  type  show-
ng  more  than  98%  identity  with  a  CDC  reference  strain  was
dentiﬁed  as  that  particular  emm  type.
FGE  analysis
ll  isolates  were  digested  by  SmaI (Promega,  Madison,  WI,
SA).  Pulsed  ﬁeld  gel  electrophoresis  (PFGE)  was  carried  out
ccording  to  the  previously  described  protocol10.
The  digested  fragments  of  DNA  were  separated  by
garose  gel  1.2%  (TBE  0.5X)  in  the  CHEF-DR  III  System  (Bio-
ad,  Hercules,  CA,  EE.UU.)  for  22  h  (0.5--40  s pulses  at
 V/cm,  120 ◦C).
The  genetic  relationship  between  the  bacterial  strains
as  evaluated  based  on  the  levels  of  similarity  among  the
maI PFGE  patterns.  A  dendrogram  was  constructed  using
he  unweighted-pair  group  method  with  arithmetic  mean
UPGMA)  algorithm  using  BioNumerics  software  version  6.0
Applied  Maths,  Kortrijk,  Belgium).
uperantigen  (SAg)  gene  detection
he  isolates  were  tested  for  the  presence  of  SAg  genes,
ncluding  speA, speB, speC, speF, speG, speH, speI, speJ,
sa,  and  smeZ25.
ntimicrobial  susceptibility  tests
isk  diffusion  tests  were  performed  by  the  Bauer  and  Kirby
ethod  according  to  CLSI  guidelines  with  5%  sheep  blood
ueller--Hinton  agar11.
Testing  disks  containing  penicillin  (PEN  10  U),  eryth-
omycin  (ERY  15  g),  clindamycin  (CLI  2  g),  tetracy-
line  (TET  30  g),  oﬂoxacin  (5  g),  peﬂoxacin  (5  g),
orﬂoxacin  (10  g)  and  levoﬂoxacin  (5  g)  were  from
ritania® Laboratories  (Buenos  Aires,  Argentina).  Incuba-
ion  was  performed  at  35 ◦C  for  24  h  in  ambient  air.
treptococcus  pneumoniae  ATCC® 4961,  Staphylococcus
ureus  ATCC® 25923,  Escherichia  coli  ATCC® 25922  and  Pseu-
omonas  aeruginosa  ATCC® 27853  were  used  as  reference
trains.
The  agar  dilution  method  was  used  for  susceptibility  test-
ng  of  ﬁve  antibiotics  (PEN,  ERY,  CLI,  TET  and  LEV)  with
%  sheep  blood  Mueller-Hinton  agar  plates  according  to
LSI  guidelines11.  Antibiotics  were  gently  provided  by  the
ervicio  de  Antimicrobianos,  INEI-ANLIS  ‘‘Dr.  Carlos  G.  Mal-
rán’’,  Buenos  Aires.  Staphylococcus  aureus  ATCC® 29213
nd  Enterococcus  faecalis  ATCC® 29212  were  used  as  refer-
nce  strains.
henotypic  expression  of  MLS  resistancehen  performing  the  disk  diffusion  tests,  blunting  of  the
LI  inhibition  zone  near  an  ERY  disk  placed  at  12  mm  from
he  edge  of  the  CLI  disk,  indicated  an  inducible  type  of
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esistance  to  macrolides,  lincosamides,  and  streptogramin
 (MLSB),  while  no  blunting  indicated  the  probability  of  the
fﬂux-mediated  M  resistance  phenotype  (resistance  only  to
4-  and  15-membered  macrolides).  Resistance  to  both  CLI
nd  ERY  indicated  a  constitutive  type  of  MLSB resistance50.
etection  of  different  macrolide  and  tetracycline
esistance  genes
enotypic  characterization  of  antimicrobial  resistance
enes  was  carried  out  by  multiplex  PCR  [erm(B),  erm(TR),
ef(A),  tet(M)  and  tet(O)  genes].  Methods  used  to
etect  antibiotic  resistance  genes  have  been  previously
escribed27,41.
esults
pidemiological,  clinical  and  demographic
haracteristics  of  the  patients  with  SDSE  invasive
isease
ne  hundred  and  eleven  invasive  infections  due  to  groups  A,
,  or  G  -hemolytic  streptococci  were  recorded.  Eighty  eight
f  them  (79.3%)  were  identiﬁed  as  S.  pyogenes,  16(14.4%)  as
GS  and  7(6.3%)  as  GCS.  The  annual  prevalence  in  Argentina
2011--2012)  was  of  at  least  23  SDSE  invasive  infections.
Most  cases  of  SDSE  invasive  infections  (65.2%)  were  diag-
osed  in  Buenos  Aires  City  and  its  surroundings  (n:  9  cases
n  Ciudad  Autónoma  de  Buenos  Aires,  n:  4  in  San  Martín,
nd  n:  2  in  Lanús).  The  rest  of  the  cases  were  detected  in
ar  del  Plata  (2),  Bahía  Blanca  (1),  General  Pico  (La  Pampa)
2),  Santa  Fe  (2)  and  Concordia  (Entre  Ríos)  (1).  STSS  was
ecorded  in  11  cases  (9  GAS,  1  SDSE  group  C  and  1  SDSE
roup  G)  and  mortality  was  6.3%  (4  adults  and  1  child  died
s  a  consequence  of  a  S.  pyogenes  infection  and  2  adults
ied  of  GGS  SDSE  infections).
Most  of  the  SDSE  isolates  were  obtained  from  blood
60.9%).  Other  foci  of  infection  were  osteoarticular  (21.7%)
nd  soft  tissue  (17.4%).  Only  GAS  was  isolated  from  pleural
ffusion  (n:  5)  and  ascites  (n:  3).
The  total  number  of  patients  was  111.  Fifty-four  of  them
ere  adults  (≥16  years  old)  and  ﬁfty-seven  were  children
<16  years  old).  With  regard  to  invasive  infections  by  SDSE,
ineteen  patients  were  adults  and  four  were  children.  The
edian  age  of  the  patients  was  54  years  old  (20  months--
0  years  old)  and  69.6%  of  the  patients  were  male.
Almost  70%  (69.6%)  of  the  infected  patients  presented
t  least  one  predisposing  condition  and  17.4%  more  than
ne.  The  most  frequent  predisposing  conditions  for  invasive
isease  were  diabetes  (n:  4),  renal  disease  (n:  2),  arterial
ypertension  (n:  2)  and  HIV  infection  (n:  2).
More  than  80%  (82.6%)  of  the  patients  had  been  treated
ith  antibiotics.  Clindamycin  was  only  administered  to
 patients  whereas  immunoglobulins  were  not  administered
t  all.  None  of  the  patients  who  died  were  treated  with
lindamycin.henotypic  identiﬁcation
ll  GCS  and  GGS  isolates  obtained  from  invasive  infections
n:  21)  were  identiﬁed  by  conventional  biochemical  tests
1
o
a
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nd  API20  Strep.  Fourteen  of  them  were  isolated  from  blood,
 from  soft  tissue,  2  from  bone  and  2  from  joint-bone  ﬂuid.
Table  1  shows  the  results  of  the  manual  biochemical  tests
nd  Table  2  summarizes  API  20  Strep  results  with  the  per-
entage  of  positive  values  obtained  from  the  bibliography.
he  percentage  of  positive  tests  is  summarized  at  the  end
f  both  tables.
Six  distinct  biochemical  proﬁles  were  obtained  using
he  API  20  Strep  identiﬁcation  system:  19%  of  the  strains
ermented  lactose  and  the  same  percentage  hydrolyzed
sculin,  86%  fermented  ribose  and  only  5%  fermented  glyco-
en.
enetic  diversity
 total  of  23  isolates,  16  GGS  and  7  GCS  were  isolated  from
nvasive  infections  and  11  different  emm  genes  were  identi-
ed.  Three  types,  stG62647  (n:  4),  stG840  (n:  3)  and  stG653
n:  3)  predominated  among  the  21  emm  invasive  strains
yped.
Figure  1  shows  the  distribution  of  invasive  types.  The
omparison  with  the  types  found  in  the  1998--1999  Argen-
inean  multicenter  study  is  also  shown.  All  the  sequences
ere  compared  with  the  CDC  emm-sequence-database.
Nineteen  distinct  PFGE  patterns  were  detected,  with  no
igniﬁcant  relationship  among  them.  The  PFGE  proﬁles  of
nvasive  strains  digested  with  the  restriction  enzyme  SmaI
re  shown  in  Figure  2. Strains  11,  13  and  18  exhibited  the
ame  pattern  and  all  were  stG62647  type.
irulence  factors
oxigenic  genes  speA, speB, speC, speF, speG, speH, speJ,
meZ  and  ssa  were  analyzed.  All  the  strains  only  carried  speJ
nd  ssa  genes  simultaneously.
ntibiotic  susceptibility  and  macrolide
nd  tetracycline  resistance  gene  study
ll  SDSE  isolates  showed  in  vitro  susceptibility  to  PEN  (MIC90
.016  g/ml)  and  to  LEV  (MIC90 0.5  g/ml).
The  percentage  of  isolates  not  susceptible  to  CLI  was
9.0%  (MIC90 0.25  g/ml),  to  ERY  26.1%  (MIC90 4  g/ml)  and
o  TET  30.4%  (MIC90 32  g/ml).
Only  one  isolate  was  found  to  be  less  susceptible  to  NOR,
EF  and  OFL  by  the  disk  diffusion  method  (13  mm,  6  mm  and
9  mm,  respectively).  Breakpoints  were  only  available  for
ﬂoxacin11 and  19  mm  was  inside  the  category  of  suscepti-
ility.
Table  3  summarizes  the  minimum  inhibitory  concentra-
ion  (MIC)  ranges,  MIC50 and  MIC90 values  of  antimicrobial
gents  for  SDSE.  Table  4  summarizes  the  macrolide  and  TET
esistance  gene  study.
The  six  isolates  with  resistance  or  diminished  sus-
eptibility  to  ERY  presented  the  following  phenotypes
nd  genotypes:  1M  [mef(A)],  2  iMLSB[erm(TR)],  and cMLSB[erm(TR)].  Isolate  14  presented  two  subpopulations:
ne  resistant  to  ERY  and  CLI  (CIM  >  256  g/ml;  cMLSB)  and
nother  resistant  to  ERY  (CIM  >  256  g/ml)  but  susceptible
o  CLI  (iMLSB phenotype).  Isolate  24  was  susceptible  to  ERY
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Table  1  Characteristics  of  Streptococcus  dysgalactiae  subsp.  equisimilis  isolated  from  invasive  infections  in  Argentina
(2011--2012). The  percentage  of  positive  tests  is  summarize  at  the  end  of  the  table
Case  ID  Sample  Group  BA  PYR  VP  ADH  ESC  STR  SBL  TRE  -GAL  -GUR
1  1  Blood  G  R  −  −  +  −  −  −  +  −  +
2 19  Blood  G  R  −  −  +  −  −  −  +  −  +
3 37  Blood  C  R  −  −  +  −  −  −  +  −  +
4 39  Blood  G  R  −  −  +  +  −  −  +  −  +
5 42  Blood  G  R  −  −  +  −  −  −  +  −  +
6 59  Bone,  SST C  R  −  −  +  −  −  −  +  −  +
7 67  Joint  G  R  −  −  +  −  −  −  +  −  +
8 69  Blood  G  R  −  −  +  −  −  −  +  −  +
9 73  Blood  G  R  −  −  +  −  −  −  +  −  +
10 89  Blood  G  R  −  −  +  −  −  −  +  −  +
11 93  Blood  C  R  −  −  +  +  −  −  +  −  +
12 143  Blood  G  R  −  −  +  −  −  −  +  −  +
13 179  Blood  C  R  −  −  +  −  −  −  +  −  +
14 187  Blood  C  R  −  −  +  −  −  −  +  −  +
15 195  Blood  G  R  −  −  +  −  −  −  +  −  +
18 227  Blood  C  R  −  −  +  −  −  −  +  −  +
19 235  Joint  G  R  −  −  +  +  −  −  +  −  +
20 237  SST  C  R  −  −  +  +  −  −  +  −  +
21 257  SST  G  R  −  −  +  −  −  −  +  −  +
23 264  SST,  DBT  foot  G  R  −  −  +  −  −  −  +  −  +
24 266  Bone,  SST  G  R  −  −  +  −  −  −  +  −  +
% of  positive  reactions  (n  =  21)  0  0  100  19  0  0  100  0  100
− −  +  V  −  −  +  −  +
BA: bacitracin, PYR: pirrolidonil-arilamidase, VP: Voges--Proskauer, ADH: arginine dihydrolase, ESC: esculin, STR: starch, SBL: sorbitol,
e, +: 
b
f
(
e
s
aTRE: trehalose, -GAL: -galactosidase, -GUR: -d-glucuronidas
DBT: diabetic.
by  the  disk  diffusion  method  but  showed  low  level  resistance
to  ERY  (MIC  =  3  g/ml)  and  carried  resistance  genes  mef(A)
and  erm(TR).
Two TET  resistant  strains  harbored  only  the  tet(M)  gene.
The  other  ﬁve  strains  carried  both  the  tet(M)  and  tet(O)
genes.
DiscussionInvasive  SDSE  infections  included  sepsis  with  an  unknown
focus,  cellulitis,  septic  arthritis,  pneumonia,  necrotizing
fascitis,  meningitis,  infectious  endocarditis,  STSS,  abscesses
at  sites  other  than  skin,  osteomyelitis,  and  others.
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Figure  1  Distribution  of  invasive  emm  types  (n  =  21,  black  bars)  an
study 1998--1999  (n  =  22,  gray  bars).positive, −: negative, V: variable, SST: skin and soft tissue, and
In  our  study  most  of  the  SDSE  isolates  were  obtained  from
lood  (n:  14).  The  rest  of  the  isolates  were  obtained
rom  bone,  joint  ﬂuid  or  soft  tissue  (n:  7).
All  our  strains  were  correctly  identiﬁed  by  both  systems
manual  and  API  20  Strep)  as  SDSE.  The  correlation  was
xcellent  between  the  tests  with  ROSCO  tablets  (esculin,
orbitol,  trehalose,  -galactosidase  and  -glucuronidase)
nd  the  same  biochemical  tests  in  the  API  20  Strep  panel.
The  frequency  of  invasive  SDSE  infection  has  increased  in
5,38 19,34,36,37,48,53,54 1,6,40sia ,  in  Europe , and  in  America over
he  years.  In  particular,  since  2003,  the  number  of  inva-
ive  SDSE  infections,  including  STSS  and  severe  soft  tissue
nfection22,26,44,  has  gradually  increased  in  Japan  each  year.
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Table  2  Phenotypic  characteristics  determined  by  the  API  20  Strep  system  for  Streptococcus  dysgalactiae  subsp.  equisimilis  isolated  from  invasive  infections  in  Argentina
(2011--2012). The  percentage  of  positive  tests  is  summarize  at  the  end  of  the  table  and  results  with  the  percentage  of  positive  values  obtained  from  bibliography  (identiﬁcation
table API  20  strep  V  7.0)
Case  ID  Sample  Group  VP  HIP  ESC  PYR  -GAL  -GUR  -GAL  PAL  LAP  ADH  RIB  ARA  MAN  SBL  LAC  TRE  INU  RAF  AMD  GLYG  HEM  Proﬁle
1  1  Blood  G  −  −  −  −  −  +  −  +  +  +  −  −  −  −  −  +  −  −  +  −  +  0  4  6  1  0  1  5
2 19  Blood  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  0  1  5
3 37  Blood  C  −  −  −  −  −  +  −  +  +  +  −  −  −  −  −  +  −  −  +  −  +  0  4  6  1  0  1  5
4 39  Blood  G  −  −  +  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  4  4  6  3  0  1  5
5 42  Blood  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  +  +  0  4  6  3  0  1  7
6 59  Bone,
SST
C  −  −  −  −  −  +  −  +  +  +  +  −  −  −  +  +  −  −  +  −  +  0  4  6  3  4  1  5
7 67  Joint  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  0  1  5
8 69  Blood  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  +  +  −  −  +  −  +  0  4  6  3  4  1  5
9 73  Blood  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  0  1  5
10 89  Blood  G  −  −  −  −  −  +  −  +  +  +  −  −  −  −  −  +  −  −  +  −  +  0  4  6  1  0  1  5
11 93  Blood  C  −  −  +  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  4  4  6  3  0  1  5
12 143  Blood  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  0  1  5
13 179  Blood  C  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  4  1  5
14 187  Blood  C  −  −  −  −  −  +  −  +  +  +  +  −  −  −  +  +  −  −  +  −  +  0  4  6  3  4  1  5
15 195  Blood  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  4  4  6  3  0  1  5
18 227  Blood  C  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  4  4  6  3  0  1  5
19 235  Joint  G  −  −  +  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  4  4  6  3  0  1  5
20 237  SST  C  −  −  +  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  4  4  6  3  0  1  5
21 257  SST  G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  0  1  5
23 264  SST,  DBT
foot
G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  −  +  −  −  +  −  +  0  4  6  3  0  1  5
24 266  Bone,
SST
G  −  −  −  −  −  +  −  +  +  +  +  −  −  −  +  +  −  −  +  −  +  0  4  6  3  4  1  5
% of  positive  reactions
(n  =  21)
0  0  19  0  0  100  0  100  100  100  86  0  0  0  19  100  0  0  100  5  100
S. dysgalactiae  subsp.
equisimilis
0  1  25  1  1  99  1  99  100  97  97  1  1  1  45  99  0  1  98  40  94
VP: Voges--Proskauer, HIP: hippurate, ESC: esculin, PYR: pyrrolidonyl--naphthylamide hydrolysis, -GAL: -galactosidase, -GUR: -glucuronidase, -GAL: -galactosidase, PAL: alkaline
phosphatase, LAP: leucinaminopeptidase, ADH: arginine dihydrolase, RIB: ribose, ARA: arabinose, MAN: manitol, SBL: sorbitol, LAC: lactose, TRE: trehalose, INU: inulin, RAF: rafﬁnose,
AMD: amigdaline, GLYG: glycogen, HEM: hemolysis, +: positive, −: negative, SST: skin and soft tissue, and DBT: diabetic.
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Figure  2  PFGE  proﬁles  of  invasive  Streptococcus  dysgalactiae  subsp.  equisimilis  (n  =  21).  The  strains  were  digested  with  the
restriction enzyme  SmaI.
Table  3  Minimum  inhibitory  concentration  (MIC)  ranges,  MIC50 and  MIC90 values  of  antimicrobial  agents  for  Streptococcus
dysgalactiae  subsp.  equisimilis
Antibiotic  Cut-off  Number  of
strains  tested
MIC50
(g/ml)
MIC90
(g/ml)
MIC  range
(g/ml)
Penicillin  S  ≤  0.125  21  0.016  0.016  0.007--0.015
Levoﬂoxacin  S  ≤  2  R  ≥  8  21  0.5  0.5  0.5--1
Clindamycin  S  ≤  0.25R  ≥  1  21  0.064  0.25  0.03--2
Erythromycin  S  ≤  0.25R  ≥  1  21  0.064  4  0.03--2
Tetracycline  S  ≤  2  R  ≥  8  21  2  32  0.125--16
MIC: minimum inhibitory concentration.
Table  4  Characteristics  of  macrolide  and  tetracycline  resistance  among  Streptococcus  disgalactiae  subsp.  equisimilis  from
Argentina
Strain  no  Tetracycline
MIC
tetM  tetO  Erythromycin
MIC
Clindamycin
MIC
Phenotype  mef(A)  erm(B)  erm(TR)
AD  Etest  AD  Etest  AD  Etest
2  8  8  +  −  2  3  0.03  0.125  iMLSB −  −  +
5 >16  64  +  +
7 >16  32  +  +
8 >16  96  +  +  >2  24  0.25  0.125  M  +  −  −
10 4  4  +  −  2  4  0.06  0.094  iMLSB −  −  +
12 >16  48  +  +
14 >2  >256  >2  >256  iMLSB/cMLSB −  +  +
20 >2  32  >2  >256  cMLSB −  −  +
21 >16  48  +  +
24 0.5  3  0.03  0.125  Susceptible  +  −  +
MIC: minimum inhibitory concentration; AD: agar dilution.
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By  the  year  2011  the  Argentine  population  was
0.73  million  inhabitants,  therefore,  the  annual  prevalence
f  SDSE  invasive  infections  (n:  23)  was  at  least  0.06/100,000
n  Argentina  during  the  2011--2012  period.  This  prevalence
eems  to  be  lower  than  that  recorded  in  a  previous  multi-
enter  study  conducted  in  1998--1999,  in  which  27  invasive
DSE  infections  were  reported  during  six-months;  however,
ore  health  institutions  participated  in  that  study40.
As  for  age  distribution,  a  population-based  surveillance
arried  out  by  Broyles  et  al.  (n:  212)6 found  that  most
atients  suffering  from  invasive  diseases  due  to  SDSE  (59.0%)
ere  adults  under  65  years  old.  Moreover,  Takahashi  et  al.
nalyzed  286  SDSE  infections  from  August  2006  to  December
00960 and  all  patients  with  invasive  infections  were  adults,
ften  elderly  (74.0%),  and  most  of  them  with  underlying
iseases.  Another  investigation58 also  indicated  that  inva-
ive  SDSE  infection  (n  =  42)  mostly  occurred  in  elderly  adults
60--80  years  old).  Severe  underlying  conditions  (i.e., dia-
etes  mellitus,  liver  or  renal  dysfunction,  and  others)  were
ssociated  with  85.7%  of  these  invasive  SDSE  infections.
In  our  study,  the  age  range  was  21--86  years;  57.1%  of
he  patients  were  adults  older  than  50  years  old  (12  out  of
1  patients).
With  regard  to  underlying  diseases,  in  U.S.  surveillance
eports,  96.2%  of  patients  with  invasive  infections  possessed
nderlying  medical  conditions13.
Similarly  to  the  study  by  Sunaoshi  et  al.58,  69.9%  of
DSE-infected  patients  in  Argentina  presented  at  least  one
nderlying  disease  and  17.4%  had  more  than  one,  being  dia-
etes  the  most  frequent  one.
Concerning  SDSE  disease  outcomes,  the  mortality  rate
n  a  Japanese  study  (12.7%)  was  similar  to  that  previously
escribed  in  Hong  Kong  and  the  United  States  (12  and
5%)6,60,64.  In  our  series,  the  mortality  rate  due  to  SDSE  inva-
ive  infections  was  8.7%  (2  cases)  and  both  were  adults.  The
ame  percentage  corresponded  to  STSS  cases.  Three  STSS
ases  and  3  deaths  were  recorded  in  a  previous  six-month
rgentinean  study40.
Neither  fatalities  nor  SDSE-mediated  STSS  were  detected
n  children.  SDSE-mediated  STSS  was  a  consequence  of  infec-
ions  due  to  types  stG840  and  stG62647  and  fatal  infections
ere  associated  with  stC74.a  and  stG62647.
The  dominant  emm  types  in  Japan  (stG6792  and  stG485)
ere  different  from  those  in  the  United  States  (stG6,
tG245,  stG2078,  and  stG643).  The  geographical  factor  may
ot  be  the  only  cause  accounting  for  such  difference  since
oth  study  periods  differed  in  these  studies  (2002--2004  vs.
006--2009)6,60.  The  emm  type  stG6792  was  the  most  fre-
uently  found  in  SDSE  Japanese  isolates  (n:  65;  22.7%)  and
as  more  strongly  related  to  poor  outcome  of  SDSE  dis-
ases  than  other  SDSE  emm  types60.  Furthermore,  those
solates  displayed  similar  DNA  proﬁles  with  PFGE  suggesting
he  clonal  expansion  of  a  speciﬁc  subpopulation  of  strains
ather  than  the  spread  of  distinct  strains.
In  another  study58,  3  emm  types,  stG6792,  stG485,
nd  stG2078,  predominated  among  the  42  invasive  strains;
trains  having  the  same  emm  type  showed  uniform  DNA  pro-
les  by  PFGE.  Moreover,  previous  reports  described  emm
ypes  and  the  DNA  proﬁles  by  PFGE  as  variable  among  SDSE
trains22,26.  In  two  other  SDSE  bacteremia  studies  carried  out
n  the  U.S.  and  Israel,  stG485, stG6, stG245  and  stG2078
ypes  were  the  most  frequently  found6,12.
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In  our  study,  19  distinct  DNA  proﬁles  by  PFGE  were
etected,  not  having  signiﬁcant  relationship  among  them.
hese  results  were  expected  because  strains  were  not  iso-
ated  in  the  context  of  an  epidemic  outbreak  and  were
btained  from  different  geographic  places.  Predominant
mm-types  were  stG62647  (n:  4),  stG840  (n:  3)  and  stG653
n:  3).  stG6792  (n:  1),  stG485  (n:  2)  and  stG2078  (n:  0)  types
ere  less  represented  in  the  present  study,  in  contrast  to
he  study  conducted  by  Sunaoshi  et  al58.  The  types  in  this
tudy  were  also  different  from  those  reported  in  the  previous
rgentinean  multicenter  study  (1998),  in  which  stG6.0  (n:
),  stG480  (n:  5)  and  stG10.0  (n:  4)  types40 predominated.
Therefore,  emm  typing  is  an  excellent  comparative  epi-
emiological  tool  for  the  analysis  of  SDSE  strains  belonging
o  different  geographical  regions  or  from  the  same  region
ut  isolated  at  different  times.
The  complete  genomic  sequence  of  SDSE  GGS  124
stG480.0)  isolated  from  patients  with  STSS  (GenBank  acces-
ion  No.  AP010935)  have  been  recently  determined.  The
enome  size  was  2.1  Mbp,  and  sequence  coverage  with
AS  genomes  was  61--63%  identity20.  Interestingly,  many
enes  encoding  virulence  factors  in  GAS  were  identiﬁed
n  SDSE.
SDSE  possesses  many  virulence  factors  shared  with  GAS28,
uch  as  M  protein,  streptolysin  O,  streptolysin  S,  streptok-
nase,  ﬁbronectin  binding  protein,  collagen  binding  protein
nd  DNase.  They  also  exhibit  homology  in  streptococcal
nhibitor  of  complement  (SIC).  However,  they  do  not  possess
ertain  virulence  factors,  such  as  some  superantigens,  cys-
eine  protease  (SPE-B)  and  the  ABC  operon52.  However,
t  was  reported  that  some  strains  of  SDSE  may  contain
uperantigen  genes,  which  were  ﬁrstly  characterized  in
.  pyogenes25,29.
It has  been  suggested  that  these  factors  were  transmitted
rom  GAS  to  SDSE  species30.
We  analyzed  speA, speB, speC, speF, speG, speH, speJ,
meZ  and  ssa  genes.  All  the  strains  harbored  only  speJ  and
sa  genes  simultaneously.
In  the  study  by  Ikebe  et  al.  from  Japan,  all  isolates  were
egative  to  speA, speB, speC, speH, speI, speJ, speL  and
peM,  however,  12  out  16  isolates  had  the  speG  gene26.
As  shown  in  the  present  study  and  in  previous  reports,
DSE  secretes  only  a  few  previously  known  superantigen
xotoxins23,35,46.
The  clinical  manifestations  of  STSS  caused  by  SDSE  are
imilar  to  EGA.  speA, speB, and  speC  genes  were  not
bserved  in  our  study  although  they  are  the  most  frequent
etected  exotoxins  in  S.  pyogenes.  Therefore,  we  suspect
hat  not  yet  identiﬁed  superantigen  exotoxins  or  exoenz-
mes  may  exist,  which  could  play  an  important  role  in  the
evelopment  of  STSS  caused  by  SDSE.
Although  60  years  have  passed  since  the  introduction  of
EN,  -hemolytic  streptococci  still  continue  being  suscepti-
le  to  this  antibiotic,  even  though  some  S.  agalactiae  strains
howed  reduced  susceptibility32.
Macrolide,  CLI  and  TET  resistance  has  been  a  matter  of
eal  concern  because  of  the  development  of  ERY-resistant  S.
yogenes  outbreaks  in  Japan,  Australia  and  several  Euro-
eans  countries  since  the  70s42,51,56.  Macrolide  and  TET
esistance  has  been  observed  both  in  GAS  and  SDSE31,43.
SDSE  isolates  (n  =  212)  collected  in  a  multicenter  surveil-
ance  study  by  Broyles  et  al.6 in  the  United  States  showed
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resistance  rates  of  28.8%  to  ERY,  4.2%  to  CLI,  and  0.9%  to
ﬂuoroquinolones.
In  Korea39,  high  frequency  of  the  TET  resistance-
mediating  tet(S)  gene  was  demonstrated  (68.8%),  while  ERY,
CLI,  and  chloramphenicol  resistance  rates  were  low  (9.4,  3.1
and  9.4%,  respectively)61.
Of  231  SDSE  isolates  in  the  study  by  Takahashi  et  al.60,
four  harbored  the  mef(A) gene,  and  13  and  six  isolates  car-
ried  the  erm(A) and  erm(B) genes,  respectively.
In  our  study,  19.0%  were  non-susceptible  to  CLI  and  26.1%
to  ERY.  Only  one  strain  was  resistant  to  ERY  (iMLSB pheno-
type,  ermTR positive)  and  no  CLI  constitutive  resistance  was
detected  in  the  previous  multicenter  study40.
In  our  study,  TET  resistance  was  30.4%.  Two  tetracycline-
resistant  strains  only  carried  the  tet(M)  gen  while  ﬁve  others
carried  both  the  tet(M)  and  tet(O)  genes.
TET  resistance  was  also  common  in  SDSE  during  the
1998--1999  period  in  Argentina  (33.3%  in  group  C  SDSE  and
40%  in  group  G  SDSE)40.  In  such  study,  TET  resistance  was
40.7%  and  all  TET  resistant  strains  carried  only  the  tet(M)
gen.
In  Portugal,  a  high  rate  of  ﬂuoroquinolone  resistance
(12%)  was  detected  between  1998  and  200547,  although  a
previous  study  from  Europe  and  the  United  States  detected
less  than  1%  resistance  toward  this  group  of  antibiotics2.
All  our  isolates  were  in  vitro  susceptible  to  LEV.  Only  one
isolate  (strain  9)  was  found  to  have  reduced  susceptibility
to  NOR,  PEF  and  OFL.
Fluoroquinolones  act  by  inhibition  of  bacterial  DNA
gyrase  and  DNA  polymerase.  The  alterations  of  these
enzymes  were  the  prevalent  mechanism  of  resistance  in  the
Streptococcus  genus24.  The  mutation  in  the  gyrA  subunits
(gyrase  DNA)  and  parC  (DNA  topoisomerase)  are  found  in  the
so-called  quinolone  resistance  determining  regions  (QRDR).
The  mechanisms  involved  in  the  small  diameters  observed
by  the  disk  diffusion  test  with  strain  9  deserve  to  be  further
studied.
In  the  future,  we  should  continue  to  survey  invasive  SDSE
infections  to  further  clarify  the  prevalence  of  infection,  the
study  of  new  virulence  factors,  the  distribution  of  emm  types
and  to  monitor  antibiotic  susceptibility  rates  in  the  Argen-
tinean  population.
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ppendix 1. National Colaborative Group for
he  Study of Streptococci and Related Bacteria
he  ‘‘National  Collaborative  Group  for  the  Study  of  Strepto-
occi  and  Related  Bacteria’’  consists  of  twenty  eight
enters  belonging  to  a  collaborative  group  for  the  study  of
treptococci  and  related  bacteria:  5  centers  from  Buenos
ires  City  (C.  Hernández,  L.  Casimir,  M.  Litterio  and  M.  del
.  Ceinos,  Hospital  de  Pediatría  Prof.  Dr.  Juan  P  Garrahan;
.  Famiglietti,  C.  Rodríguez  and  S.  García,  Hospital  de  Clíni-
as  G.  J.  San  Martín;  C.  Vay,  Sanatorio  Mater  Dei;  D.  Ballester
nd  F.  Amalfa,  Hospital  Parmenio  Pin˜ero;  R.  Pereda,  Hos-
ital  Pedro  Elizalde),  4  from  Rosario  (N.  Borda  and
.  Notario,  Hospital  Espan˜ol;  E.  Sutich,  J.  Pérez,  G.  Cera,
.  J.  Spoletti,  I.  Demaría  and  D.  Aguila,  Hospital  Provincial
el  Centenario;  A.  Ernst,  A.  Badano  and  A.  Aletti,  Hos-
ital  de  Nin˜os  Víctor  J.  Vilela;  A.  Ponessa,  R.  Notario,  T.
ambandé  and  L.  All,  Cátedra  de  Microbiología,  Facultad
e  Ciencias  Médicas  Universidad  Nacional  de  Rosario),  2
rom  Santa  Fe  (S.  Virgolini,  Ma.  R.  Barone  and  G.  Ezcurra,
ospital  de  Nin˜os  Dr.  O.  Alassia;  E.  Méndez,  Hospital  Dr.  José
aría  Cullen)  2  from  Córdoba  (M.  Bottiglieri,  Clínica  Privada
eina  Fabiola;  P.  Montanaro,  A.  Oreccini  and  A.  Garnero,
ospital  de  Nin˜os  de  la  Santísima  Trinidad),  2  from  San  Juan
H.  Castro,  Hospital  Marcial  Quiroga;  O.  Navarro,  M.  López
nd  M.  Mengual,  Hospital  Guillermo  Rawson)  and  1  each
rom  Mar  del  Plata  (M.  Vallejo,  N.  Rosales,  V.  Fanjul  and
.  Gordovil,  Hospital  Privado  de  la  Comunidad),  San  Rafael
A.  Acosta  and  C.  Baldoni,  Hospital  Teodoro  Schestakow),
endoza  (M.  A.  Di  Stéfano  and  L.  Contreras,  Hospital
entral  de  Mendoza),  Lanús  (A.  Togneri,  L.  Podestá  and
.  Pérez,  Hospital  Evita),  La  Plata  (A.  Pacha,  Hospital  San
uan  de  Dios),  Pilar  (V.  Vilches,  Hospital  Austral),  Bahía
lanca  (M.  Rizzo,  Ma.  Luz  Benvenutti  and  L.  Giordano,
ospital  General  de  Agudos  Dr.  José  Penna),  Neuquén  (M.  R.
ún˜ez,  Hospital  Provincial  Dr.  Castro  Rendón),  Gral.  Pico
S.  Cirimele,  A.  Baroni  and  D.  Ruderman,  Establecimiento
sistencial  Gobernador  Centeno),  Santa  Rosa  (G.  Almada,
ospital  Lucio  Molas),  Esquel  (O.  Daher,  Hospital  Zonal  de
squel),  Posadas  (M.E.  von  Specht,  L.  Leguizamón  and  Oscar
ópez,  Hospital  Provincial  de  Pediatría  Dr.  F.  Barreyro),  and
oncordia  (Ma.  Ofelia  Moulins,  L.  Otaegui  and  L.  Bernhardt,
ospital  Masvernat).
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